Ranitiget en es it fr

Ranitiget Brand names, Ranitiget Analogs

Ranitiget Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranitiget Chemical_Formula


Ranitiget RX_link


Ranitiget fda sheet

Ranitiget FDA

Ranitiget msds (material safety sheet)

Ranitiget MSDS

Ranitiget Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranitiget Molecular Weight

314.405 g/mol

Ranitiget Melting Point

69-70 oC

Ranitiget H2O Solubility

24.7 mg/mL

Ranitiget State


Ranitiget LogP


Ranitiget Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranitiget Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranitiget Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranitiget Absorption

Approximately 50% bioavailability orally.

Ranitiget side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranitiget Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranitiget Organisms Affected

Humans and other mammals